Esco Lifesciences (1891571D SP) Pre-IPO: A Profitable Revenue Growth Saga
Esco Lifesciences is looking to raise $300M through HK IPO. During 2019–2021, by leveraging on demand for its products, the company recorded...
3k Views
Esco Lifesciences Pre-IPO Tearsheet
Esco Lifesciences Group (1891571D SP) is looking to raise about US$300m in its upcoming HK IPO. The deal will be run by JP Morgan, BofA and Jefferies.
712 Views